findmyKOL

Vinita Sehgal, MD

Basic profile

Icahn School of Medicine at Mount Sinai

ORCIDNone on fileNPI↗
✓ Full record
RegionNew York, NY · NortheastSpecialtyNephrologyFocusNephrology
Last active 2022findmyKOL type: RegionalLatest publication2022Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Vinita Sehgal is a Nephrology physician affiliated with Icahn School of Medicine at Mount Sinai. OpenAlex indexes 32 publications with 1,262 citations (h-index 18).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
32publications

Distinct works indexed by OpenAlex.

1,262citations

Total citations across indexed works.

18h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

5 E 98th St
12th Flr
New York, NY 100296501

Telephone

212-987-3100

Registry record last updated 27 Sept 2019.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    29.3%
    Beta blocker8.4%
    Metoprolol Tartrate32%Carvedilol29%Metoprolol Succinate27%Labetalol Hcl11%
    Part D<11 patients
    Calcium channel blocker8%
    Nifedipine Er62%Amlodipine Besylate38%
    Part D≥25 patients

    + 5 more classes in this area

  • Metabolism & gastrointestinal

    26.4%
    Corticosteroid10.1%
    Prednisone100%
    Part D≥76 patients
    H2 blocker6.1%
    Famotidine100%
    Part D≥39 patients

    + 5 more classes in this area

  • Anti-infectives

    15.6%
    Short-acting sulfonamides5.9%
    Sulfamethoxazole-Trimethoprim100%
    Part D≥41 patients
    Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor2.4%
    Valacyclovir100%
    Part D≥15 patients

    + 8 more classes in this area

Where care is delivered (Part B)24.8% facility · 75.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”